Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: Clinical staging and functional information in a single study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 2, 2013, Pages 156-165

  Ippolito, Davide ^a   Capraro, Cristina ^a   Guerra, Luca ^a,b   De Ponti, Elena ^a,b   Messa, Cristina ^a,b   Sironi, Sandro ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

FDG PET CT; Functional imaging; Lung cancer; Metabolic parameters; Perfusion CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; FEASIBILITY STUDY; FEMALE; FLOW RATE; GLUCOSE METABOLISM; HISTOLOGY; HUMAN; INFORMED CONSENT; LUNG BIOPSY; LUNG BLOOD FLOW; LUNG BLOOD VOLUME; LUNG CANCER; LUNG SCINTISCANNING; MALE; PRIMARY TUMOR; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; WHOLE BODY CT; WHOLE BODY PET;

AGED; BIOPSY; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; PERFUSION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84874105210     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2273-y     Document Type: Article

References (29)

1. WHO. Cancer. World Health Organization.
2. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995;75 1 Suppl:191-202.
3. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229(2):526-33.
4. Nabi HA, Zubeldia JM. Clinical applications of (18)F-FDG in oncology. J Nucl Med Technol. 2002;30:3-9.
5. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47(1):161-78.
6. Duffy JP, Eibl G, Reber HA, Hines OJ. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer. 2003;2:12. doi: 10.1186/1476-4598-2-12.
7. Bisdas S, Spicer K, Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR Am J Neuroradiol. 2008;29:1376-81.
8. Miles KA. Tumor angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol. 1999;30:198-205.
9. Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology. 2005;234:785-92.
10. Ma SH, Le HB, Jia BH, Wang ZX, Xiao ZW, Cheng XL, et al. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer. 2008;8:186-202.
11. Wang J, Wu N, Cham MD, Song Y. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol. 2009;193(4):1090-6.
12. Li Y, Yang ZG, Chen TW, Chen HJ, Sun JY, Lu YR. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer. 2008;61(1):44-53.
13. Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumor size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med. 2006;33(1):22-8.
14. Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2008;101(6):758-64.
15. Kiessling F, Boese J, Corvinus C, Ederle J, Zuna I, Schoenberg S, et al. Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol. 2004;14(7):1226-33.
16. Kohler HH, Barth PJ, Siebel A, Gerharz EW, Bittinger A. Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol. 1996;77:650-4.
17. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal carcinoma. Br J Urol. 1997;80:401-4.
18. Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol. 2001;32:1209-15.
19. Rajendran JG, Mankoff DA, O'Sullivan F, Peterson LM, Schwartz DL, Conrad EU, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10(7):2245-52.
20. Rajendran JG, Schwartz DL, O'Sullivan J, Peterson LM, Ng P, Scharnhorst J, et al. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res. 2006;12:5435-41.
21. Miles KA, Griffiths MR, Fuentes MA. Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules. Radiology. 2001;220(2):548-53.
22. Cappabianca S, Porto A, Petrillo M, Greco B, Reginelli A, Ronza F, et al. Preliminary study on the correlation between grading and histology of solitary pulmonary nodules and contrast enhancement and [18F]fluorodeoxyglucose standardised uptake value after evaluation by dynamic multiphase CT and PET/CT. J Clin Pathol. 2011;64:114-9.
23. Ng QS, Goh V, Fichte H, Klotz E, Fernie P, Saunders MI, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology. 2006;239(2):547-53.
24. Ng QS, Goh V, Klotz E, Fichte H, Saunders MI, Hoskin PJ, et al. Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol. 2006;187(4):1079-84.
25. Veit-Haibach P, Treyer V, Strobel K, Soyka JD, Husmann L, Schaefer NG, et al. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging. 2010;35(5):528-36.
26. Goh V, Halligan S, Gharpuray A, Wellsted D, Sundin J, Bartram CI. Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology. 2008;247(3):726-32.
27. Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol. 2011;120(2):270-4.
28. Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17:115-22.
29. Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69(2):328-33.